Basanite, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
Basanite, Inc. reports significant revenue decline, negative gross profit, zero cash, and substantial doubt about its ability to continue as a going concern in its latest 10-Q filing.
OTC.Pink
Basanite, Inc. reports significant revenue decline, increased losses, and substantial doubt about its ability to continue as a going concern, amidst paused manufacturing and mounting debt.
OTC.Pink
Basanite Inc.'s Q1 2025 results reveal a decrease in revenue and continued net losses, highlighting the company's struggle with manufacturing constraints and limited working capital.
OTC.Pink
Basanite Inc.'s Q3 2024 results reveal ongoing financial difficulties, including net losses and a working capital deficiency, while the company focuses on restructuring and securing additional funding.
OTC.Pink
Basanite Inc.'s Q2 2024 results reveal ongoing financial struggles with reduced revenue and operating losses, alongside efforts to address manufacturing and compliance issues.
OTC.Pink
Basanite Inc. reports a net loss of $287,958 for the first quarter of 2024, with revenue decreasing to $59,449, highlighting ongoing financial and operational challenges.